OnKure Therapeutics, Inc.
OKUR
$2.47
-$0.06-2.37%
NASDAQ
06/30/2024 | 03/31/2024 | ||||
---|---|---|---|---|---|
Net Income | -48.27% | -0.86% | |||
Total Depreciation and Amortization | -1.99% | 20.80% | |||
Total Amortization of Deferred Charges | -- | -- | |||
Total Other Non-Cash Items | 1,594.39% | 4.90% | |||
Change in Net Operating Assets | 522.21% | -161.19% | |||
Cash from Operations | 39.10% | -51.41% | |||
Capital Expenditure | -11.11% | 72.73% | |||
Sale of Property, Plant, and Equipment | -- | -- | |||
Cash Acquisitions | -- | -- | |||
Divestitures | -- | -- | |||
Other Investing Activities | -- | -- | |||
Cash from Investing | -11.11% | 72.73% | |||
Total Debt Issued | -- | -- | |||
Total Debt Repaid | -- | -- | |||
Issuance of Common Stock | 0.00% | 11.11% | |||
Repurchase of Common Stock | -- | -- | |||
Issuance of Preferred Stock | -- | -- | |||
Repurchase of Preferred Stock | -- | -- | |||
Total Dividends Paid | -- | -- | |||
Other Financing Activities | -- | -- | |||
Cash from Financing | 58,580.00% | 0.00% | |||
Foreign Exchange rate Adjustments | -- | -- | |||
Miscellaneous Cash Flow Adjustments | -- | -- | |||
Net Change in Cash | 94.21% | -50.90% | |||